InvestorsHub Logo
Followers 33
Posts 3538
Boards Moderated 0
Alias Born 11/17/2013

Re: flipper44 post# 669887

Sunday, 02/04/2024 11:33:25 AM

Sunday, February 04, 2024 11:33:25 AM

Post# of 700351
I do not know much about the Pfizer-Seagen take over, but I Googled a little information. Even from the little I learned, the comparison is not really fair. It is comparing NWBO to Seagen as though they are quite similar. They are not.

Basically you are comparing great potential in the case of NWBO to the current actual accomplished reality. Here is the basic comparison just prior to closing as I see it.

1. Current revenue: Seagen -Almost $2 Bil per year VS. NWBO - nearly NIL
2, Current approved drugs: Seagen - 4 VS NWBO - None
3. Outstanding shares: Seagen - about 200,000,000 VS NWB) about 1.7 Billion shares fully diluted
4. Potential a decade from now: Seagen - Bought out for growth of actual abilities to better future potential VS NWBO - GREAT revolutionary potential for ALL cancers but yet to be proven and actualized.

Pfizer wanted a bird in hand and bought it, rather than two or more birds in the woods that it still had to catch.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News